2019
DOI: 10.1001/jamainternmed.2018.6989
|View full text |Cite
|
Sign up to set email alerts
|

County-Level Opioid Prescribing in the United States, 2015 and 2017

Abstract: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
59
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(62 citation statements)
references
References 11 publications
2
59
1
Order By: Relevance
“…6 These sensitivity models only cover the years 2007-2017 because of data availability. Data on the prescription opioid rate were accessed from the CDC which acquired prescription data from IQVIA, a health information technology and clinical research company ( Centers for Disease Control and Prevention, 2019 ; Guy et al, 2020 ). Unfortunately, there is no comparable dataset which measures the supply of illegal drugs.…”
Section: Methodsmentioning
confidence: 99%
“…6 These sensitivity models only cover the years 2007-2017 because of data availability. Data on the prescription opioid rate were accessed from the CDC which acquired prescription data from IQVIA, a health information technology and clinical research company ( Centers for Disease Control and Prevention, 2019 ; Guy et al, 2020 ). Unfortunately, there is no comparable dataset which measures the supply of illegal drugs.…”
Section: Methodsmentioning
confidence: 99%
“…However, while opioid prescribing has declined in recent years , opioid overdose death rates have largely continued to rise , leading to concern that efforts to reduce opioid prescribing may be ineffective or even causing harm . However, given the ongoing rise in heroin use, including fentanyl‐tainted heroin , population rates of opioid overdose may obscure trends in incident OUD among the opioid‐naive.…”
Section: Introductionmentioning
confidence: 99%
“…In response, there have been multiple initiatives to limit opioid prescribing [7][8][9][10][11][12], which could reduce the burden of opioid use disorder (OUD) and its associated harms by avoiding initial exposure to prescription opioids among individuals receiving treatment for pain [13][14][15] or by promoting safer treatment regimens for those who do start opioid analgesics [16,17], thus mitigating OUD and overdose risk. Alternatively, these measures may also limit non-medical use of prescription opioids if they reduce diversion of opioid analgesic medication [3,[18][19][20][21] However, while opioid prescribing has declined in recent years [11,22], opioid overdose death rates have largely continued to rise [23], leading to concern that efforts to reduce opioid prescribing may be ineffective or even causing harm [24][25][26][27]. However, given the ongoing rise in heroin use, including fentanyl-tainted heroin [28][29][30], population rates of opioid overdose may obscure trends in incident OUD among the opioid-naive.…”
Section: Introductionmentioning
confidence: 99%
“…In the United States, the annual opioid prescribing rate reached a high of 81.2 prescriptions per 100 persons in 2010 . This rate decreased to 58.7 per 100 persons in 2017 (Guy et al 2019). While efforts have been made to restructure opioid prescribing, a subset of surgical patients require these medications postoperatively.…”
Section: Introductionmentioning
confidence: 99%